Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma.

MLA

Yu, H., et al. “Axl Receptor Tyrosine Kinase Is a Potential Therapeutic Target in Renal Cell Carcinoma.” British Journal of Cancer, vol. 113, no. 4, Aug. 2015, pp. 616–25. EBSCOhost, https://doi.org/10.1038/bjc.2015.237.

APA

Yu, H., Liu, R., Ma, B., Li, X., Yen, H.-Y., Zhou, Y., Krasnoperov, V., Xia, Z., Zhang, X., Bove, A. M., Buscarini, M., Parekh, D., Gill, I. S., Liao, Q., Tretiakova, M., Quinn, D., Zhao, J., & Gill, P. S. (2015). Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma. British Journal of Cancer, 113(4), 616–625. https://doi.org/10.1038/bjc.2015.237

Chicago

Yu, H, R Liu, B Ma, X Li, H-Y Yen, Y Zhou, V Krasnoperov, et al. 2015. “Axl Receptor Tyrosine Kinase Is a Potential Therapeutic Target in Renal Cell Carcinoma.” British Journal of Cancer 113 (4): 616–25. doi:10.1038/bjc.2015.237.